Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ALMS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
48 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 36 days ago
Red flags: 0
199 filers reported a long position in ALMS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| AyurMaya Capital Management Company, LP | $426M | 15.1M | Unchanged |
| BlackRock, Inc. | $231.3M | 8.2M | +14.6% |
| FMR LLC | $190.5M | 6.8M | +595.1% |
| Deep Track Capital, LP | $178.6M | 6.3M | -6.3% |
| Samsara BioCapital, LLC | $178.6M | 6.3M | Unchanged |
| Foresite Capital Management V, LLC | $165.9M | 5.9M | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ | $146.3M | 5.2M | +58.2% |
| venBio Partners LLC | $127.4M | 4.5M | Unchanged |
| Foresite Capital Management VI LLC | $119.5M | 4.2M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $118.6M | 4.2M | +4.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.